Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Application: It is designed as a once-weekly subcutaneous injection
Patients were subdivided by whether they received surgery alone or adjuvant 5FU-based chemotherapy and subsequently grouped based on the median overall survival into either good outcome or poor outcome
doi: 10.1007/s00125-018-4670-7 56 GuJNoeAChandraPAl-FayoumiSLigueros-SaylanMSarangapaniRet al
"Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing." Cell Tissue Res
These shRNAs were in the pLKO.1 vector (shACTL6A-1 and shACTL6A-2)
US$ 21.32
US$ 24.22
US$ 25.35
